The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
It is unclear if HIV-1 variants lose the ability to prime naïve CD8+ cytotoxic T lymphocytes (CTL) during progressive, untreated infection. We conducted a comprehensive longitudinal analysis of viral evolution and its impact on primary and memory CD8+ T cell responses pre-seroconversion (SC), post-SC, and during combination antiretroviral therapy (cART). Memory T cell responses targeting autologous virus variants reached a nadir by 8 years post-SC with development of AIDS, followed by a transient enhancement of anti-HIV-1 CTL responses upon initiation of cART. We show broad and high magnitude primary T cell responses to late variants in pre-SC T cells, comparable to primary anti-HIV-1 responses induced in T cells from uninfected persons. Despite evolutionary changes, CD8+ T cells could still be primed to HIV-1 variants. Hence, vaccination against late, mutated epitopes could be successful in enhancing primary reactivity of T cells for control of the residual reservoir of HIV-1 during cART. © 2013.
Description
Keywords
Autologous viral variants, Cart, Hiv-1, Memory t cell responses, Primary t cell responses, Adult, Anti-hiv agents, Cd8-positive t-lymphocytes, Cohort studies, Epitopes, t-lymphocyte, Evolution, molecular, Histocompatibility antigens class i, Hiv infections, Humans, Male, T-lymphocytes, Viral proteins, Abacavir, Antiretrovirus agent, Cd8 antigen, Efavirenz, Efavirenz plus emtricitabine plus tenofovir disoproxil, Epitope, Lamivudine, Nelfinavir, Saquinavir, Zidovudine, Acquired immune deficiency syndrome, Antigen specificity, Article, Cd8+ t lymphocyte, Genetic conservation, Human, Human cell, Human immunodeficiency virus 1, Human immunodeficiency virus 1 infection, Immunoreactivity, Memory t lymphocyte, Nonhuman, Priority journal, Seroconversion